Mirum Pharmaceuticals, Inc. (MIRM)
97.27
+1.62
(+1.69%)
USD |
NASDAQ |
Apr 08, 11:28
Mirum Pharmaceuticals Cash from Investing (TTM) : -23.95M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | -414.24M |
| Insmed, Inc. | -64.58M |
| Ionis Pharmaceuticals, Inc. | -277.78M |
| BridgeBio Pharma, Inc. | -22.34M |
| Cogent Biosciences, Inc. | -399.53M |